Santhera Pharmaceuticals Ag

(OTC) SPHDF

Current Price$23.25

Market Cap$344.91M

Since IPO (2009)-91%

5 Year-25%

1 Year+58%

1 Month+0%

Santhera Pharmaceuticals Ag Financials at a Glance

Market Cap

$344.91M

Revenue (TTM)

CHF 116.33M

Net Income (TTM)

-CHF 91.21M

EPS (TTM)

-$4.50

P/E Ratio

-5.17

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$23.25

Volume

Open

$23.25

Price

$23.25

Volume

Open

$23.25

Previous Close

$23.25

Daily Range

$23.25 - $23.25

52-Week Range

$12.28 - $23.25

Estimated Earnings Date

Sep 21, 2026

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$23.25

Volume

Open

$23.25

Previous Close

$23.25

Daily Range

$23.25 - $23.25

52-Week Range

$12.28 - $23.25

Estimated Earnings Date

Sep 21, 2026

SPHDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Santhera Pharmaceuticals Ag

Industry

Biotechnology

Sector

Health Care

Employees

93.6

CEO

Dario Eklund

Website

www.santhera.com

Headquarters

Pratteln, BL 4133, CH

SPHDF Financials

Key Financial Metrics (TTM)

Gross Margin

18.74%

Operating Margin

-48.99%

Net Income Margin

-63.79%

Return on Equity

684.83%

Return on Capital

-44.00%

Return on Assets

-33.25%

Earnings Yield

-19.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$344.91M

Shares Outstanding

14.83M

Volume

Avg. Volume

105.484

Financials (TTM)

Gross Profit

CHF 38.07M

Operating Income

-CHF 71.14M

EBITDA

-CHF 48.49M

Operating Cash Flow

-CHF 70.30M

Capital Expenditure

-CHF 274.02K

Free Cash Flow

-CHF 70.57M

Cash & ST Invst.

CHF 22.45M

Total Debt

CHF 97.81M

Santhera Pharmaceuticals Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CHF 53.20M

-46.5%

Gross Profit

CHF 22.93M

-76.6%

Gross Margin

43.11%

N/A

Market Cap

$344.91M

N/A

Market Cap/Employee

$4.42M

N/A

Employees

N/A

Net Income

-CHF 10.41M

-113.3%

EBITDA

CHF 480.23K

-99.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CHF 22.45M

-26.1%

Total Debt

CHF 97.81M

+353.9%

Accounts Receivable

CHF 26.05M

+5820.6%

Inventory

CHF 24.88M

+1273.8%

Long Term Debt

CHF 74.07M

+4037.0%

Short Term Debt

CHF 14.85M

-31.0%

Return on Assets

-33.25%

N/A

Return on Invested Capital

-44.02%

N/A

Free Cash Flow

-CHF 14.22M

-122.7%

Operating Cash Flow

-CHF 14.17M

-122.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLNCFSilence Therapeutics plc

SLNCFSilence Therapeutics plc$1.50+0.00%

IPHYFInnate Pharma S.A.

IPHYFInnate Pharma S.A.$1.65+0.00%

GNFTFGenfit S.a.

GNFTFGenfit S.a.$10.75+0.00%

MLLCFMolecular Partners AG

MLLCFMolecular Partners AG$3.80+0.00%

JWCTFJW (Cayman) Therapeutics Co. Ltd

JWCTFJW (Cayman) Therapeutics Co. Ltd$0.20-4.37%

NDTPNDT Pharmaceuticals Inc.

NDTPNDT Pharmaceuticals Inc.$0.30-1.52%

BXPHFBotanix Pharmaceuticals Limited

BXPHFBotanix Pharmaceuticals Limited$0.01+14.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AGENAgenus

AGENAgenus$6.12+0.83%

AALAmerican Airlines Group

AALAmerican Airlines Group$16.31-0.04%

ONDSOndas

ONDSOndas$6.96-0.04%

NOKNokia

NOKNokia$11.69-0.06%

PATHUiPath

PATHUiPath$11.85+0.01%

VEEETwin Vee Powercats

VEEETwin Vee Powercats$24.86+4.16%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$139.14-0.04%

Questions About SPHDF

What is the current price of Santhera Pharmaceuticals Ag?

Santhera Pharmaceuticals Ag is trading at $23.25 per share.

What is the 52-week range for Santhera Pharmaceuticals Ag?

Over the past 52 weeks, Santhera Pharmaceuticals Ag has traded between $12.28 and $23.25.

How much debt does Santhera Pharmaceuticals Ag have?

As of the most recent reporting period, Santhera Pharmaceuticals Ag reported total debt of CHF 123.40M.

How much cash does Santhera Pharmaceuticals Ag have on hand?

Santhera Pharmaceuticals Ag reported CHF 28.32M in cash and cash equivalents in its most recent financial results.

What is Santhera Pharmaceuticals Ag’s dividend yield?

Santhera Pharmaceuticals Ag does not currently have a dividend yield.

Santhera Pharmaceuticals Ag

Santhera Pharmaceuticals Ag Financials at a Glance

SPHDF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Santhera Pharmaceuticals Ag

SPHDF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Santhera Pharmaceuticals Ag Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SPHDF

What is the current price of Santhera Pharmaceuticals Ag?

What is the 52-week range for Santhera Pharmaceuticals Ag?

How much debt does Santhera Pharmaceuticals Ag have?

How much cash does Santhera Pharmaceuticals Ag have on hand?

What is Santhera Pharmaceuticals Ag’s dividend yield?

Premium Investing Services